3137 results for «2379»

Filter By

3137 results

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

18 Nov 2025 – From PCR London Valves 2025

This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...

Cardiovalve hits the TARGET: advancing transcatheter valve replacement

Cracking the tricuspid code "the Bicaval revolution"

16 Nov 2025 – From PCR London Valves 2025

This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.

Cracking the tricuspid code 'the Bicaval revolution'

Day case TAVI - The future standard of care for most TAVI patients

16 Nov 2025 – From PCR London Valves 2025

Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...

Day case TAVI - The future standard of care for most TAVI patients

Hotline - TAVI - Part 1

16 Nov 2025 – From PCR London Valves 2025

This comprehensive session examines the latest evidence and clinical trial data on TAVI, including comparisons of balloon-expandable versus self-expanding valves in failed bioprostheses, techniques to reduce coronary obstruction risk, and real-world outcomes across diverse populations. Cost-effectiveness analyses and longitudinal studies further inform best practices for optimizing...

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

17 Nov 2025 – From PCR London Valves 2025

Discover the latest advancements in the VitaFlow transcatheter aortic valve implantation (TAVI) device. This session highlights the electronically enabled VitaFlow Liberty system, delivering consistent immediate and mid-term clinical results. Watch real-world demonstrations of complex cases, including heavily calcified aortas and pure aortic regurgitation, and get a...

Exceptional engineering, predictable outcomes - Latest development of the VitaFlow TAVI device

Valve interventions in congenital heart disease

16 Nov 2025 – From PCR London Valves 2025

This session presents complex valve interventions in congenital heart disease, highlighting challenging cases such as positional hypoxaemia due to iatrogenic atrial defects, navigating residual shunts after PFO closure, and transcatheter pulmonary valve replacement in native right ventricular outflow tracts without pre-stenting. It also examines an intriguing...

From innovation to intervention: optimising procedural techniques in tricuspid TEER

17 Nov 2025 – From PCR London Valves 2025

Explore advanced strategies for tricuspid TEER in this PCR London Valves 2025 session.

Through real-world cases and interactive simulation, learn how to optimise outcomes in complex tricuspid anatomy, manage challenges posed by pacemaker leads, and enhance procedural efficiency using the TriClip G5 device.

Gain practical insights on clipping...

From innovation to intervention: optimising procedural techniques in tricuspid TEER

Breakout session on Simul-Imaging

16 Nov 2025 – From PCR London Valves 2025

This session focuses on the evolution and impact of simul-imaging in interventional cardiology. It reviews historical perspectives on the FIM procedure, the role of simulation in accelerating the learning curve, and innovative approaches to simulation-based training. Additionally, the session highlights cutting-edge imaging innovations from major industry...

From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients

16 Nov 2025 – From PCR London Valves 2025

This session explores a full spectrum of therapeutic options for mitral and tricuspid regurgitation, focusing on the PASCAL Precision system for targeted repair and the SAPIEN M3 transcatheter mitral valve replacement. Through beating heart simulators, case discussions, and clinical evidence, participants will understand the versatility and...

From repair to replacement: a portfolio of options for your mitral and tricuspid regurgitation patients

Featured research: innovative solutions for mitral valve repair and replacement

16 Nov 2025 – From PCR London Valves 2025

This featured research session offers a comprehensive exploration of mitral valve interventions, encompassing electrosurgical device removal techniques, transcatheter mitral valve replacement (TMVR) outcomes, and transcatheter edge-to-edge repair (TEER) in complex clinical contexts such as heart transplantation and acute valve syndromes. It further examines pulmonary artery systolic...

Featured research: innovative solutions for mitral valve repair and replacement

Getting the full potential of the supra-annular valve in a changing landscape

16 Nov 2025 – From PCR London Valves 2025

This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.

Getting the full potential of the supra-annular valve in a changing landscape

TAVI in aortic regurgitation

16 Nov 2025 – From PCR London Valves 2025

This session addresses the challenges and innovations in transcatheter aortic valve implantation (TAVI) for aortic regurgitation. It covers complex clinical scenarios such as severe regurgitation post-endocarditis, alternative access routes complicated by prosthesis embolisation, and the use of dedicated TAVI devices in non-tricuspid valves. The session also...

TAVI-in-TAVI

16 Nov 2025 – From PCR London Valves 2025

This session explores the nuanced field of TAVI-in-TAVI procedures, focusing on valve durability considerations between bovine and porcine valves, strategies for redo TAVI post valve-in-valve, and advanced interventions to secure coronary flow such as inter-valvular stenting. It highlights complex anatomical challenges including aberrant coronary origins and...

Featured research: advances in TAVI for aortic regurgitation and severe stenosis

16 Nov 2025 – From PCR London Valves 2025

This session delivers an in-depth analysis of innovative research in transcatheter aortic valve implantation (TAVI). It includes pivotal studies such as the LANDMARK trial subanalysis on cardiac damage in severe aortic stenosis patients, long-term efficacy comparisons of balloon- and self-expanding valves, and evaluations of valve performance...

Featured research: advances in TAVI for aortic regurgitation and severe stenosis

Single operator TAVI: where expertise meets consistency

18 Nov 2025 – From PCR London Valves 2025

This session addresses the concept of single operator transcatheter aortic valve implantation (TAVI), emphasizing the integration of expertise with procedural consistency. Follow a discussion on the benefits of simplifying TAVI to a single operator approach facilitated by an electronically enabled delivery system. The session offers a...

Single operator TAVI: where expertise meets consistency

Complex combined interventions

16 Nov 2025 – From PCR London Valves 2025

This session presents complex combined interventions tackling multiple valvular and structural heart challenges simultaneously. It highlights innovative procedural approaches such as the 'super combo' techniques, strategies for managing deteriorative mitral regurgitation post-tricuspid valve replacement, and comprehensive management of torrential tricuspid regurgitation within rheumatic multivalvular disease contexts,...

Hotline - Valvular and structural interventions

16 Nov 2025 – From PCR London Valves 2025

This session presents pivotal advances in valvular and structural heart interventions, covering the SMART-MV trial on mitral valvotomy safety, outcomes of TAVR patients with tricuspid regurgitation undergoing TEER, and the application of the FLOWer embolic protection system across structural heart procedures. Additionally, it explores the impact...

Featured research: clinical outcomes and real-world evidence in modern TAVI practice

16 Nov 2025 – From PCR London Valves 2025

This session presents featured research on Transcatheter Aortic Valve Implantation (TAVI), analyzing clinical impacts of prosthesis oversizing, same-day discharge experiences, and comparative outcomes of intra-annular versus supra-annular self-expanding valves. It also reviews nationwide TAVR data from Germany and meta-analyses assessing TAVI performance in centers without on-site...

Featured research: clinical outcomes and real-world evidence in modern TAVI practice

Featured research: innovations, safety and evolving pathways in modern TAVI care

16 Nov 2025 – From PCR London Valves 2025

This session addresses contemporary challenges in TAVI, including management of acute valve syndrome through service innovations and the application of Valvosoft non-invasive ultrasound therapy in severe aortic stenosis. It also explores complications such as infective endocarditis post-TAVI, evaluates the feasibility of same-day discharge protocols, and assesses...

Featured research: innovations, safety and evolving pathways in modern TAVI care

TAVI and coronary artery disease

16 Nov 2025 – From PCR London Valves 2025

This session focuses on the interplay between TAVI and coronary artery disease, discussing high-risk TAVR cases requiring complex left main PCI with prophylactic ECMO support. It provides guidance on timing and strategies for managing concomitant coronary artery disease in TAVI patients, addressing the critical decision-making process...

Didn’t find what you were looking for?